<DOC>
	<DOCNO>NCT00313157</DOCNO>
	<brief_summary>The purpose study compare effect metoprolol , verapamil , diltiazem carvedilol ventricular rate , work capacity quality life patient chronic atrial fibrillation .</brief_summary>
	<brief_title>RATe Control Atrial Fibrillation</brief_title>
	<detailed_description>This randomise , single blind , cross-over study compare efficacy metoprolol 100 mg o.d. , verapamil 240 mg o.d. , diltiazem 360 mg o.d . carvedilol 25 mg o.d . reduce ventricular rate atrial fibrillation . A total 60 patient include , minimum 20 women.Patients receive drug regimen random sequence . Each regimen administer 3 week , ensure steady-state drug concentration attain provide adequate washout previous treatment . Following regimen , exercise ECG Holter registration perform patient undergo laboratory evaluation complete QoL-forms . They start next randomly assign treatment regimen , entire sequence treatment schedule complete .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Diltiazem</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<criteria>Persistent permanent atrial fibrillation ventricular rate &gt; 80/min rest and/or &gt; 100/min average daytime . Male female , age &gt; 18 . Hypersensitivity contraindication metoprolol , verapamil , diltiazem carvedilol . Coronary heart disease heart failure Systolic blood pressure &lt; 100 mmHg AVconduction disturbance Severe hepatic renal dysfunction Thyrotoxicosis Ongoing treatment Digitalis Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Atrial fibrillation</keyword>
</DOC>